[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600832":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":34,"locations":43,"responsibleParty":63,"collaborators":25,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":25,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":25,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":46,"whyStopped":25,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Prisma Health-Upstate","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment","ACTIVE_COMPARATOR","Vasopressin- 20 mL of a dilute solution (5 units of Vasopressin in 20cc injectable saline)",[13],"Drug: Intracervical injection of Vasopressin",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","20 mL of saline",[19],"Drug: Intracervical Injection of saline",[21,26],{"type":22,"name":23,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Intracervical injection of Vasopressin",[9],null,{"type":22,"name":27,"description":27,"armGroupLabels":28,"otherNames":25},"Intracervical Injection of saline",[15],[30],{"name":31,"affiliation":32,"role":33},"Paul Miller, MD","Prisma Health","STUDY_DIRECTOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Patti Parker, BSN","CONTACT","864-455-1510","patti.parker@prismahealth.org",{"name":31,"role":37,"phone":41,"phoneExt":25,"email":42},"894-455-1600","paul.miller@prismahealth.org",[44],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"The OB\u002FGYN Center","RECRUITING","Greenville","South Carolina","29605","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-82.39401,34.85262,{"lat":56,"lon":55},[59],{"name":60,"role":37,"phone":61,"phoneExt":25,"email":62},"Erica Lowing, MD","864-455-1600","erica.lowing@prismahealth.org",{"type":64,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100600832","phase-4-intracervical-vasopressin-100600832",false,"NCT07102615","Intracervical Vasopressin","Intracervical Vasopressin for Completion of Hysteroscopic Removal of Retained Products of Conception","Inclusion Criteria:\n\n* Women\n* Aged 18-51\n* Undergoing surgical management for retained products of conception, postpartum retained products of conception or 1st trimester missed or incomplete abortion\n\nExclusion Criteria:\n\n* Hemodynamic instability\n* Active hemorrhage- soaking pad\u002Fhour\n* Allergy to vasopressin\n* Concern for intrauterine arteriovenous malformation\n* Inability to consent","FEMALE","18 Years","51 Years",{"count":76,"type":77},50,"ESTIMATED","INTERVENTIONAL",[80],"PHASE4","This randomized study looks at whether using a medicine injected into the cervix of the uterus (intracervical), called vasopressin, helps to achieve better removal of retained products of conception (RPOC). RPOC means that after a pregnancy has ended (through miscarriage, abortion, or delivery), some parts of the pregnancy tissue, usually from the placenta or fetus, have stayed in the uterus. A hysteroscopic removal of RPOC is one type of treatment. This is a surgical procedure where a doctor uses a small camera attached to a thin tube (called a hysteroscope) to look inside the uterus.\n\nThe main goal of the study is :\n\n• To add to the existing research through this study to see if the injection of intracervical vasopressin leads to improved completion rates of hysteroscopic management of RPOC.\n\nParticipants will:\n\n• would be randomized to receive either vasopressin intracervical injection or a placebo injection (non-active saline) during your procedure. Information from the procedure will be collected from the participant's medical record.",[83],"Retained Products of Conception",[85,86,87],"retained products of conception","intracervical","hysteroscopy","2025-10-31",{"date":90,"type":91},"2025-11-04","ACTUAL",{"date":93,"type":91},"2025-10-30",{"date":95,"type":77},"2026-12-01",{"name":5,"class":6},1]